SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-18-051116
Filing Date
2018-02-21
Accepted
2018-02-21 07:06:20
Documents
5
Period of Report
2018-02-21

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d461993d6k.htm 6-K 367166
2 GRAPHIC g461993footer.jpg GRAPHIC 8601
3 GRAPHIC g461993kazia.jpg GRAPHIC 5068
4 GRAPHIC g461993snap2.jpg GRAPHIC 8303
5 GRAPHIC g461993snap3.jpg GRAPHIC 9112
  Complete submission text file 0001193125-18-051116.txt   411626
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 18627033
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1